Azithromycin
| Antibiotics |
32302411 2020. Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19
32534189 2020. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.
32398343 2020. Should azithromycin be used to treat COVID-19? A rapid review.
32511867 2020. Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin with Different Dosing Regimens used in COVID-19 Clinical Trials.
32510734 2020. Azithromycin and COVID-19Prompt Early Use at First Signs of this Infection in Adults and Children An Approach Worthy of Consideration.
32533455 2020. Azithromycin for COVID-19: More Than Just an Antimicrobial?
32550240 2020. Azithromycin Should Not Be Used to Treat COVID-19.
32426812 2020. Reduction of coronavirus burden with mass azithromycin distribution.
32622008 2020. Azithromycin and SARS-CoV-2 infection: where we are now and where we are going.
32696429 2020. Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines.
| 32804426 2020. Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy. |
32816219 2020. Use of Azithromycin in COVID-19: A Cautionary Tale.
32839756 2020. Azithromycin: The First Broad-spectrum Therapeutic.
32871342 2020. Azithromycin: The First Broad-spectrum Therapeutic.
| 32853038 2020. Azithromycin in the treatment of COVID-19: a review. |
32853672 2020. Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
| 32857620 2020. Azithromycin Downregulates Gene Expression of IL-1beta and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2. |
32881982 2020. Observational study of azithromycin in hospitalized patients with COVID-19.
32896292 2020. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
32896293 2020. Azithromycin for severe COVID-19.
32956575 2020. The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin.
32969125 2020. Azithromycin in viral infections.
33045350 2020. Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2.
| 33211371 2020. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin. |
33243134 2020. COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases.
C7339112 2020. Azithromycin ? An Antibiotic to Fight COVID-19?
